Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation

被引:97
作者
Chiaretti, S
Li, XC
Gentleman, R
Vitale, A
Wang, KS
Mandelli, F
Foà, R
Ritz, J
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA USA
[4] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
关键词
D O I
10.1158/1078-0432.CCR-04-2165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To characterize gene expression signatures in acute lymphocytic leukemia (ALL) cells associated with known genotypic abnormalities in adult patients. Experimental Design: Gene expression profiles from 128 adult patients with newly diagnosed ALL were characterized using high-density oligonucleotide microarrays. All patients were enrolled in the Italian GIMEMA multicenter clinical trial 0496 and samples had > 90% leukemic cells. Uniform phenotypic, cytogenetic, and molecular data were also available for all cases. Results: T-lineage ALL was characterized by a homogeneous gene expression pattern, whereas several subgroups of B-lineage ALL were evident. Within B-lineage ALL, distinct signatures were associated with ALL1/AF4 and E2A/PBX1 gene rearrangements. Expression profiles associated with ALL1/AF4 and E2A/PBX1 are similar in adults and children. BCR/ABL(+) gene expression pattern was more heterogeneous and was most similar to ALL without known molecular rearrangements. We also identified a set of 83 genes that were highly expressed in leukemia blasts from patients without known molecular abnormalities who subsequently relapsed following therapy. Supervised analysis of kinase genes revealed a high-level FLT3 expression in a subset of cases without molecular rearrangements. Two other kinases (PRKCB1 and DDR1) were highly expressed in cases without molecular rearrangements, as well as in BCR/ABL-positive ALL. Conclusions: Genomic signatures are associated with phenotypically and molecularly well defined subgroups of adult ALL. Genomic profiling also identifies genes associated with poor outcome in cases without molecular aberrations and specific genes that may be new therapeutic targets in adult ALL.
引用
收藏
页码:7209 / 7219
页数:11
相关论文
共 49 条
[1]   Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification [J].
Armstrong, SA ;
Kung, AL ;
Mabon, ME ;
Silverman, LB ;
Stam, RW ;
Den Boer, ML ;
Pieters, R ;
Kersey, JH ;
Sallan, SE ;
Fletcher, JA ;
Golub, TR ;
Griffin, JD ;
Korsmeyer, SJ .
CANCER CELL, 2003, 3 (02) :173-183
[2]   FLT3 mutations in childhood acute lymphoblastic leukemia [J].
Armstrong, SA ;
Mabon, ME ;
Silverman, LB ;
Li, AH ;
Gribben, JG ;
Fox, EA ;
Sallan, SE ;
Korsmeyer, SJ .
BLOOD, 2004, 103 (09) :3544-3546
[3]   MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia [J].
Armstrong, SA ;
Staunton, JE ;
Silverman, LB ;
Pieters, R ;
de Boer, ML ;
Minden, MD ;
Sallan, SE ;
Lander, ES ;
Golub, TR ;
Korsmeyer, SJ .
NATURE GENETICS, 2002, 30 (01) :41-47
[4]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[5]   FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression [J].
Brown, P ;
Levis, M ;
Shurtleff, S ;
Campana, D ;
Downing, J ;
Small, D .
BLOOD, 2005, 105 (02) :812-820
[6]   Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival [J].
Chiaretti, S ;
Li, XC ;
Gentleman, R ;
Vitale, A ;
Vignetti, M ;
Mandelli, F ;
Ritz, J ;
Foa, R .
BLOOD, 2004, 103 (07) :2771-2778
[7]   Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study:: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome [J].
Cimino, G ;
Elia, L ;
Mancini, M ;
Annino, L ;
Anaclerico, B ;
Fazi, P ;
Vitale, A ;
Specchia, G ;
Di Raimondo, F ;
Recchia, A ;
Cuneo, A ;
Mecucci, C ;
Pane, F ;
Saglio, G ;
Foà, R ;
Mandelli, F .
BLOOD, 2003, 102 (06) :2014-2020
[8]  
Cimino G, 2001, HAEMATOLOGICA, V86, P436
[9]   Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events [J].
Debernardi, S ;
Lillington, DM ;
Chaplin, T ;
Tomlinson, S ;
Amess, J ;
Rohatiner, A ;
Lister, TA ;
Young, BD .
GENES CHROMOSOMES & CANCER, 2003, 37 (02) :149-158
[10]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042